MB

Mayurkumar Bhimsibhai Bariya

Active Director Director DIN 10139152
DIN 10139152 First appointment Apr 2023 Primary industry Consumer Products
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Mayurkumar Bhimsibhai Bariya

Data last updated:

Mayurkumar Bhimsibhai Bariya is a Director at Stenova Medex Private Limited (since 2023). The company operates in Consumer Products.

DIN 10139152
Primary Designation Director
Industry Consumer Products
First Appointment 28 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Stenova Medex Private Limited U46497GJ2023PTC140634
Director28 Apr 20232023Active

Board colleagues of Mayurkumar Bhimsibhai Bariya

NameDINCompanyDesignation
Parth Abhangi10139153Stenova Medex Private LimitedDirector

Directorship timeline

Open interactive timeline →
Stenova Medex Private Limited
Premium access

Shareholding and investment profile for Mayurkumar Bhimsibhai Bariya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mayurkumar Bhimsibhai Bariya

Mayurkumar Bhimsibhai Bariya currently holds 1 directorship: Stenova Medex Private Limited (Director, since 28 Apr 2023).

Mayurkumar Bhimsibhai Bariya was first appointed on 28 Apr 2023 as Director at Stenova Medex Private Limited.

The current boards of Mayurkumar Bhimsibhai Bariya's companies include Parth Abhangi (Stenova Medex Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available